Effectiveness of Adjunctive Mother Tinctures to Individualized Homeopathic Treatment of Chronic Obstructive Pulmonary Diseases: An Open Randomized Pragmatic Pilot Trial

Abstract

Background We evaluated whether adjunctive mother tinctures (MTs) to individualized homeopathy (IH) have significant effect beyond IH alone in treatment of chronic obstructive pulmonary diseases (COPD).

Methods An open, randomized (1:1; IH + MT versus IH only), two parallel arms, pragmatic trial (n = 60) was conducted at National Institute of Homoeopathy, India. Primary outcomes were forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), and FEV1/FVC, measured at baseline and 6 months; secondary outcomes were Bengali COPD assessment test (CAT-B) questionnaire and (clinical COPD questionnaire) CCQ-B, measured at baseline, and after 3 and 6 months; and exacerbation frequencies during 6 months.

Results Five patients dropped out (IH + MT: 3, IH: 2). Though intragroup changes were significant, intergroup differences of spirometric changes over 6 months were nonsignificant (Mann Whitney U test); FEV1 (P _0–6= 0.761), FVC (P _0–6 = 0.512), and FEV1/FVC (P _0–6 = 0.741). Over 3 and 6 months, differences of changes in CAT-B (P _0–3 = 0.553 and P _0–6 = 0.900) and CCQ-B (P _0–3 = 0.428 and P _0–6 = 0.953) scores were also nonsignificant. Exacerbation frequencies were nonsignificant between groups over 6 months (p = 1.000).

Conclusion Although adjunctive MTs to IH could not produce any treatment benefits in COPD, the trial being underpowered, cautious interpretation is necessary.

Trial registration CTRI/2018/04/013394.

Keywords

Homeopathy - chronic obstructive pulmonary disease - mother tinctures - clinical trial

Authors' Contribution

AB, PS, SP, AC, JM, MK and SS: concept, design, literature search, data interpretation, and preparation of the article; AB, LN, SAB, AK and RG: clinical study and data acquisition; SSA and AB: data compilation, management and master chart preparation; SSA, AB, JM, MK and SS: data interpretation, statistical analysis and preparation of the article. All the authors reviewed and approved the final article.

• References

• 1 Lozano R, Naghavi M, Foreman K. , et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380 (9859): 2095-2128
• 2 Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006; 3 (11) e442
• 3 Jones PW. Health status and the spiral of decline. COPD 2009; 6 (01) 59-63
• 4 Han MK, Muellerova H, Curran-Everett D. , et al. GOLD 2011 disease severity classification in COPDGene: a prospective cohort study. Lancet Respir Med 2013; 1 (01) 43-50
• 5 Jones P, Harding G, Wiklund I, Berry P, Leidy N. Improving the process and outcome of care in COPD: development of a standardised assessment tool. Prim Care Respir J 2009; 18 (03) 208-215
• 6 Jones PW, Brusselle G, Dal Negro RW. , et al. Properties of the COPD assessment test in a cross-sectional European study. Eur Respir J 2011; 38 (01) 29-35
• 7 van der Molen T, Willemse BW, Schokker S, ten Hacken NH, Postma DS, Juniper EF. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes 2003; 1: 13
• 8 Global Initiative for Chronic Obstructive Lung Disease, Inc. Pocket guide to COPD diagnosis, management, and prevention. A guide for health care professionals. 2017 ed. Global Initiative for Chronic Obstructive Lung Disease. http://www.goldcopd.org . Published 2017. Accessed May 11, 2017
• 9 Raju K, Gupta J, Singh V. , et al. An open clinical trial to find the usefulness of a group of pre-defined homeopathic medicines in the management of simple and mucopurulent chronic bronchitis. Asian J Homeopathy 2010; 14-21
• 10 Delzoppo G. Terapie della bronchite asmatica in etá pediatrica: protocollo omeopatico vs. protocollo allopatico corrispondente die riferimento. Med Biol (Milano) 2004; 3-7
• 11 Diefenbach M, Schilken J, Steiner G, Becker HJ. Homeopathic therapy in respiratory tract diseases. Evaluation of a clinical study in 258 patients. Zeitschr für Allgemeinmedizin 1997; 73: 308-314
• 12 Schmidt W. Zur rherapie der chronischen bronchitis—randomisierte doppelblindstudie mit asthmakhell. Therapiewoche 1987; 37 (29) 2803-2808
• 13 Conde Diez S, Viejo Casas A, Garcia Rivero JL, Lopez Caro JC, Ortiz Portal F, Diaz Saez G. Impact of a homeopathic medication on upper respiratory tract infections in COPD patients: Results of an observational, prospective study (EPOXILO). Respir Med 2019; 146: 96-105
• 14 Koley M, Saha S, Arya JS. , et al. A study on drug utilization and prescription habits of physicians in a government homeopathic hospital in West Bengal, India. J Integr Med 2013; 11 (05) 305-313
• 15 Ullman A, Hedner J, Svedmyr N. Inhaled salmeterol and salbutamol in asthmatic patients. An evaluation of asthma symptoms and the possible development of tachyphylaxis. Am Rev Respir Dis 1990; 142 (03) 571-575
• 16 Donohue JF, Wise R, Busse WW. , et al. Efficacy and safety of ipratropium bromide/albuterol compared with albuterol in patients with moderate-to-severe asthma: a randomized controlled trial. BMC Pulm Med 2016; 16 (01) 65
• 17 Boericke W. New Manual of Homeopathic Materia Medica with Repertory. 3rd revised and augmented ed. 2010. New Delhi, India: B Jain Publishers (P) Ltd.;
• 18 Ghose SC. Drugs of Hindoosthan. 8th ed. 1980. Kolkata, India: Hahnemann Publishing Company Pvt. Ltd.;
• 19 Satti J. Homeopathic drug standardization. Seminars in Integrative Medicine. 2005; 3 (04) 113-122 . Available at: https://www.sciencedirect.com/science/article/abs/pii/S1543115006000056 . DOI: https://doi.org/10.1016/j.sigm.2006.04.001
• 20 https://www.ccrhindia.nic.in/index1.aspx?Isid=8682&lev=2&lid=6622&Regid=0&langid=1 . Accessed October 30, 2019
• 21 Banerjee A, Nahar L, Bhat SA. , et al. Psychometric analysis of the Bengali clinical chronic obstructive pulmonary disease questionnaire. Indian J Respir Care 2020; 9 (01) 40-46
• 22 Cleophas TJ. Clinical trials and p-values, beware of the extremes. Clin Chem Lab Med 2004; 42 (03) 300-304
• 23 Zwarenstein M, Treweek S, Gagnier JJ. , et al; CONSORT group; Pragmatic Trials in Healthcare (Practihc) group. Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ 2008; 337: a2390
• 24 Dean ME, Coulter MK, Fisher P, Jobst K, Walach H. Reporting data on homeopathic treatments (RedHot): a supplement to CONSORT. Homeopathy 2007; 96 (01) 42-45
• 25 Micceri T. The unicorn, the normal curve, and other improbable creatures. Psychol Bull 1989; 105: 156-166